News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
SITC – JITC Has Reached an Impact Factor of 10.6 and a CiteScore of 17.8 in 2024!
Society for Immunotherapy of Cancer/sitcancer.org
Jul 3, 2025, 08:20

SITC – JITC Has Reached an Impact Factor of 10.6 and a CiteScore of 17.8 in 2024!

Society for Immunotherapy of Cancer (SITC) posted on LinkedIn:

“SITC is proud to share that the Journal for ImmunoTherapy of Cancer (JITC) has reached an Impact Factor of 10.6 and a CiteScore of 17.8 in 2024!

As an open access, peer-reviewed journal, JITC is committed to serve as a targeted outlet for the publication of original research articles, literature reviews, position papers and discussion on all aspects of tumor immunology and cancer immunotherapy–from basic research to clinical application.

Explore the latest high-impact articles:

1. Single-cell RNA sequencing of baseline PBMCs predicts ICI efficacy and irAE severity in patients with NSCLC.

Authors: Gyeong Dae Kim, So-I Shin, Pureum Sun, Jeong Eun Lee, Chaeuk Chung, Yea Eun Kang, Da Hyun Kang, Jihwan Park

2. EZH2 inhibition and 5-azacytidine enhance antitumor immunity in PTEN-deficient glioblastoma by activation viral mimicry response.

Authors: Dandan Zhu, Zeying Li, Huolun Feng, Jiabin Zheng, Xiao Xiao, Zuda Huang, Liangying Zheng, Jieqing Guo, Fa Ling, Yong Li, Fan Xing

3. Tumor glyco-immunology, glyco-immune checkpoints and immunotherapy.

Authors: Salomé S. Pinho, Matthew S. Macauley, Heinz Läubli

4. Development and validation of the Immune Profile Score (IPS), a novel multiomic algorithmic assay for stratifying outcomes in a real-world cohort of patients with advanced solid cancer treated with immune checkpoint inhibitors.

Authors: Alia D Zander, Rossin Erbe, Yan Liu, Ailin Jin, Seung Won Hyun, Sayantoni Mukhopadhyay, Ben Terdich, Mario G Rosasco, Nirali Patel, Brett M Mahon, A Kate Sasser, Michelle A Ting-Lin, Halla Nimeiri, Justin Guinney, Douglas Adkins, Matthew Zibelman, Kyle A Beauchamp, Chithra Sangli, Michelle M Stein, Timothy Taxter, Timothy Chan, Sandip P Patel, Ezra E W Cohen.”

More posts featuring Society for Immunotherapy of Cancer.

Chaeuk Chung Da Hyun Kang Dandan Zhu Fa Ling Fan Xing Gyeong Dae Kim Heinz Läubli Huolun Feng Jeong Eun Lee Jiabin Zheng Jieqing Guo Jihwan Park JITC Liangying Zheng Matthew S. Macauley NSCLC Pureum Sun Salomé S. Pinho So-I Shin Society for Immunotherapy of Cancer Xiao Xiao Yea Eun Kang Yong Li Zeying Li Zuda Huang
Special Coverage
New Paper Alert
Aug 14, 2025, 00:38
Survival Benefit of High TMB and BRAF Mutation in Advanced Melanoma on Adjuvant Anti–PD-1
Insight
Aug 13, 2025, 21:09
Amir Manbachi: Fighting Glioblastoma with Sound Waves
Voices
Aug 13, 2025, 20:52
Chiara Corti: Ranking Oncologists in Social Media - What Could Go Wrong?
Insight
Aug 13, 2025, 20:36
Talha Badar: Brief Thread on Clonal Hematopoiesis
Voices
Aug 13, 2025, 20:22
Stephen V Liu: Cataloging Success - Repotrectinib's Efficacy in a ROS1 NSCLC Resistance Case
Opinion
Aug 13, 2025, 20:15
Tom Powles: Opening a New Area for Cis-Ineligible MIBC
Voices
Aug 13, 2025, 19:46
Mario Balsa: ESMO Guidelines for Localized Rectal Cancer Are Here
Science
Aug 13, 2025, 19:37
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers
Science
Aug 13, 2025, 19:21
Naveen Pemmaraju: Prognostic Impact of NPM1 Co-Mutation in FLT3-Mutated AML
Voices
Aug 13, 2025, 19:12
Narjust Florez: Are Women More Affected by Lung Cancer Surgery?
Insight
Aug 13, 2025, 18:42
Petros Grivas: Geriatric Assessment in Bladder Cancer - A Personalized Approach
Insight
Aug 13, 2025, 17:28
Elena Laakmann: Exploring the Brain Imaging Screening in Metastatic Breast Cancer